Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
J Virol
    February 2024
  1. HUANG H, Lei X, Zhao C, Qin Y, et al
    Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving IFIT3.
    J Virol. 2024;98:e0168223.
    >> Share

  2. STOLL GA, Nikolopoulos N, Zhai H, Zhang L, et al
    Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
    J Virol. 2024;98:e0177723.
    >> Share

  3. LI Z, Lai Y, Qiu R, Tang W, et al
    Hyperacetylated microtubules assist porcine deltacoronavirus nsp8 to degrade MDA5 via SQSTM1/p62-dependent selective autophagy.
    J Virol. 2024 Feb 14:e0000324. doi: 10.1128/jvi.00003.
    >> Share

  4. VANSLAMBROUCK JM, Neil JA, Rudraraju R, Mah S, et al
    Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
    J Virol. 2024 Feb 9:e0180223. doi: 10.1128/jvi.01802.
    >> Share

  5. BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al
    Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
    J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
    >> Share

  6. NIU S, Zhao Z, Liu Z, Rong X, et al
    Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
    J Virol. 2024 Feb 2:e0115723. doi: 10.1128/jvi.01157.
    >> Share

  7. HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
    SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
    J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
    >> Share

  8. ZHANG X-Z, Wang J, Tian W-J, You J-L, et al
    Phospho-eIF4E stimulation regulates coronavirus entry by selective expression of cell membrane-residential factors.
    J Virol. 2024 Feb 1:e0194823. doi: 10.1128/jvi.01948.
    >> Share

    January 2024
  9. SHEN S, Guo H, Li Y, Zhang L, et al
    SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
    J Virol. 2024 Jan 30:e0190923. doi: 10.1128/jvi.01909.
    >> Share

  10. LI Z, Xiao W, Yang Z, Guo J, et al
    Cleavage of HDAC6 to dampen its antiviral activity by nsp5 is a common strategy of swine enteric coronaviruses.
    J Virol. 2024 Jan 30:e0181423. doi: 10.1128/jvi.01814.
    >> Share

  11. ZHANG S, Wang J, Liu X, Kan Z, et al
    Pemetrexed alleviates piglet diarrhea by blocking the interaction between porcine epidemic diarrhea virus nucleocapsid protein and Ezrin.
    J Virol. 2024;98:e0162523.
    >> Share

  12. SCHMIED K, Ehmann R, Kristen-Burmann C, Ebert N, et al
    An RNA replicon system to investigate promising inhibitors of feline coronavirus.
    J Virol. 2024 Jan 18:e0121623. doi: 10.1128/jvi.01216.
    >> Share

  13. DULIN H, Barre RS, Xu D, Neal A, et al
    Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
    J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571.
    >> Share

  14. BERTZBACH LD, Seddar L, von Stromberg K, Ip W-H, et al
    The adenovirus DNA-binding protein DBP.
    J Virol. 2024 Jan 10:e0188523. doi: 10.1128/jvi.01885.
    >> Share

  15. YIN L, Liu X, Yao Y, Yuan M, et al
    Gut microbiota-derived butyrate promotes coronavirus TGEV infection through impairing RIG-I-triggered local type I interferon responses via class I HDAC inhibition.
    J Virol. 2024 Jan 10:e0137723. doi: 10.1128/jvi.01377.
    >> Share

  16. FARJO M, Koelle K, Martin MA, Gibson LL, et al
    Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection.
    J Virol. 2024 Jan 4:e0161823. doi: 10.1128/jvi.01618.
    >> Share

  17. DEY S, Mondal A
    Unveiling the role of host kinases at different steps of influenza A virus life cycle.
    J Virol. 2024 Jan 4:e0119223. doi: 10.1128/jvi.01192.
    >> Share

  18. LI K, Verma A, Li P, Ortiz ME, et al
    Adaptation of SARS-CoV-2 to ACE2(H353K) mice reveals new spike residues that drive mouse infection.
    J Virol. 2024 Jan 3:e0151023. doi: 10.1128/jvi.01510.
    >> Share

  19. RASMUSSEN AL, Gronvall GK, Lowen AC, Goodrum F, et al
    Virology-the path forward.
    J Virol. 2024 Jan 3:e0179123. doi: 10.1128/jvi.01791.
    >> Share

    December 2023
  20. GAO Q, Weng Z, Feng Y, Gong T, et al
    KPNA2 suppresses porcine epidemic diarrhea virus replication by targeting and degrading virus envelope protein through selective autophagy.
    J Virol. 2023;97:e0011523.
    >> Share

  21. FU Z, Xiang Y, Fu Y, Su Z, et al
    DYRK1A is a multifunctional host factor that regulates coronavirus replication in a kinase-independent manner.
    J Virol. 2023 Dec 15:e0123923. doi: 10.1128/jvi.01239.
    >> Share

  22. BOLLAND W, Michel V, Planas D, Hubert M, et al
    High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
    J Virol. 2023 Dec 13:e0135123. doi: 10.1128/jvi.01351.
    >> Share

  23. JERONIMO PMC, Aksenen CF, Duarte IO, Lins RD, et al
    Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation.
    J Virol. 2023 Dec 13:e0140423. doi: 10.1128/jvi.01404.
    >> Share

  24. GAO W, Wang L, Cui W, Wang H, et al
    Deubiquitinase USP1 regulates sarbecovirus ORF6 protein function.
    J Virol. 2023 Dec 12:e0143723. doi: 10.1128/jvi.01437.
    >> Share

  25. PHAM TX, Huynh TTX, Choi J, Lee J-B, et al
    SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.
    J Virol. 2023 Dec 5:e0173723. doi: 10.1128/jvi.01737.
    >> Share

  26. ZAYOU L, Prakash S, Dhanushkodi NR, Quadiri A, et al
    A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection.
    J Virol. 2023 Dec 1:e0109623. doi: 10.1128/jvi.01096.
    >> Share

  27. SO RTY, Chu DKW, Hui KPY, Mok CKP, et al
    Amino acid substitution L232F in non-structural protein 6 identified as a possible human-adaptive mutation in clade B MERS coronaviruses.
    J Virol. 2023 Dec 1:e0136923. doi: 10.1128/jvi.01369.
    >> Share

    November 2023
  28. NARAYANAN KK, Amaya M, Tsang N, Yin R, et al
    Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins.
    J Virol. 2023;97:e0062123.
    >> Share

  29. LI K, Huntwork RHC, Horn GQ, Abraha M, et al
    Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
    J Virol. 2023 Nov 29:e0107023. doi: 10.1128/jvi.01070.
    >> Share

  30. YANG S, Huang X, Li S, Wang C, et al
    Linoleic acid: a natural feed compound against porcine epidemic diarrhea disease.
    J Virol. 2023 Nov 27:e0170023. doi: 10.1128/jvi.01700.
    >> Share

  31. WANG Z, He W, Li C, Chen Y, et al
    The role of lysosomes as intermediates in betacoronavirus PHEV egress from nerve cells.
    J Virol. 2023 Nov 27:e0133823. doi: 10.1128/jvi.01338.
    >> Share

  32. DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
    Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
    J Virol. 2023 Nov 21:e0151123. doi: 10.1128/jvi.01511.
    >> Share

  33. BRAGAZZI CUNHA J, Leix K, Sherman EJ, Mirabelli C, et al
    Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection.
    J Virol. 2023 Nov 17:e0127623. doi: 10.1128/jvi.01276.
    >> Share

  34. NIU X, Liu M, Yang S, Xu J, et al
    A recombination-resistant genome for live attenuated and stable PEDV vaccines by engineering the transcriptional regulatory sequences.
    J Virol. 2023 Nov 16:e0119323. doi: 10.1128/jvi.01193.
    >> Share

  35. ALRUWAILI M, Armstrong S, Prince T, Erdmann M, et al
    SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption.
    J Virol. 2023 Nov 6:e0042423. doi: 10.1128/jvi.00424.
    >> Share

    October 2023
  36. PAHMEIER F, Lavacca T-M, Goellner S, Neufeldt CJ, et al
    Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis.
    J Virol. 2023 Oct 31:e0087823. doi: 10.1128/jvi.00878.
    >> Share

  37. YANG X, Kong N, Qin W, Zhai X, et al
    PGAM5 degrades PDCoV N protein and activates type I interferon to antagonize viral replication.
    J Virol. 2023 Oct 26:e0147023. doi: 10.1128/jvi.01470.
    >> Share

  38. OLARTE-CASTILLO XA, Plimpton L, McQueary H, Sun Y, et al
    Detection and characterization of novel luchacoviruses, genus Alphacoronavirus, in saliva and feces of meso-carnivores in the northeastern United States.
    J Virol. 2023 Oct 26:e0082923. doi: 10.1128/jvi.00829.
    >> Share

  39. UNDI RB, Ahsan N, Larabee JL, Darlene-Reuter N, et al
    Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network.
    J Virol. 2023 Oct 20:e0119423. doi: 10.1128/jvi.01194.
    >> Share

  40. KUMAR S, Delipan R, Chakraborty D, Kanjo K, et al
    Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity.
    J Virol. 2023 Oct 20:e0092223. doi: 10.1128/jvi.00922.
    >> Share

  41. YE G, Pan R, Bu F, Zheng J, et al
    Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
    J Virol. 2023 Oct 19:e0144823. doi: 10.1128/jvi.01448.
    >> Share

  42. SUN H, Wang Y, Chen X, Jiang Y, et al
    Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant.
    J Virol. 2023 Oct 19:e0113723. doi: 10.1128/jvi.01137.
    >> Share

  43. JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al
    Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.
    J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336.
    >> Share

  44. LI J, Zhao S, Zhang B, Huang J, et al
    A novel recombinant S-based subunit vaccine induces protective immunity against porcine deltacoronavirus challenge in piglets.
    J Virol. 2023 Oct 17:e0095823. doi: 10.1128/jvi.00958.
    >> Share

  45. GAO J, Tang YD, Hu W, Zheng C, et al
    Correction for Gao et al., "When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2".
    J Virol. 2023 Oct 16:e0098523. doi: 10.1128/jvi.00985.
    >> Share

  46. WU Y, Shi J, He X, Lu J, et al
    Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.
    J Virol. 2023 Oct 16:e0127923. doi: 10.1128/jvi.01279.
    >> Share

  47. SUO X, Wang J, Wang D, Fan G, et al
    DHA and EPA inhibit porcine coronavirus replication by alleviating ER stress.
    J Virol. 2023 Oct 16:e0120923. doi: 10.1128/jvi.01209.
    >> Share

  48. MIURA K, Suzuki Y, Ishida K, Arakawa M, et al
    Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells.
    J Virol. 2023 Oct 13:e0042623. doi: 10.1128/jvi.00426.
    >> Share

  49. MAHE D, Bourgeau S, da Silva J, Schlederer J, et al
    SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo.
    J Virol. 2023 Oct 13:e0110423. doi: 10.1128/jvi.01104.
    >> Share

  50. RIBO-MOLINA P, Weiss HJ, Susma B, van Nieuwkoop S, et al
    4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1.
    J Virol. 2023 Oct 12:e0132523. doi: 10.1128/jvi.01325.
    >> Share

  51. FANG P, Zhang H, Cheng T, Ding T, et al
    Porcine deltacoronavirus accessory protein NS6 harnesses VPS35-mediated retrograde trafficking to facilitate efficient viral infection.
    J Virol. 2023 Oct 10:e0095723. doi: 10.1128/jvi.00957.
    >> Share

  52. MCMAHON M, Tan J, O'Dell G, Kirkpatrick Roubidoux E, et al
    Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
    J Virol. 2023 Oct 6:e0105723. doi: 10.1128/jvi.01057.
    >> Share

  53. KIMURA I, Yamasoba D, Nasser H, Ito H, et al
    Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
    J Virol. 2023 Oct 5:e0101123. doi: 10.1128/jvi.01011.
    >> Share

    September 2023
  54. CHEN Y, Liu X, Zheng JN, Yang LJ, et al
    N-linked glycoproteins and host proteases are involved in swine acute diarrhea syndrome coronavirus entry.
    J Virol. 2023 Sep 29:e0091623. doi: 10.1128/jvi.00916.
    >> Share

  55. ZHAO Y, Sui L, Wu P, Li L, et al
    EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8.
    J Virol. 2023 Sep 29:e0102823. doi: 10.1128/jvi.01028.
    >> Share

  56. LI J, Gui Q, Liang FX, Sall J, et al
    The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication.
    J Virol. 2023 Sep 28:e0050723. doi: 10.1128/jvi.00507.
    >> Share

  57. PENG Q, Fan B, Song X, He W, et al
    Genetic signatures associated with the virulence of porcine epidemic diarrhea virus AH2012/12.
    J Virol. 2023 Sep 21:e0106323. doi: 10.1128/jvi.01063.
    >> Share

  58. SCHOEN A, Holzer M, Muller MA, Wallerang KB, et al
    Functional comparisons of the virus sensor RIG-I from humans, the microbat Myotis daubentonii, and the megabat Rousettus aegyptiacus, and their response to SARS-CoV-2 infection.
    J Virol. 2023 Sep 20:e0020523. doi: 10.1128/jvi.00205.
    >> Share

  59. FUJITA S, Kosugi Y, Kimura I, Tokunaga K, et al
    Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2.
    J Virol. 2023 Sep 19:e0099023. doi: 10.1128/jvi.00990.
    >> Share

  60. KRCHLIKOVA V, Lotke R, Haussmann I, Reinisova M, et al
    Independent loss events of a functional tetherin gene in galliform birds.
    J Virol. 2023 Sep 15:e0080323. doi: 10.1128/jvi.00803.
    >> Share

  61. XING M, Wang Y, Wang X, Liu J, et al
    Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants.
    J Virol. 2023 Sep 14:e0072423. doi: 10.1128/jvi.00724.
    >> Share

  62. DAHAL S, Clayton K, Cabral T, Cheng R, et al
    On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine.
    J Virol. 2023 Sep 14:e0039623. doi: 10.1128/jvi.00396.
    >> Share

  63. KERR CM, Parthasarathy S, Schwarting N, O'Connor JJ, et al
    PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell- and tissue-specific manner.
    J Virol. 2023 Sep 11:e0088523. doi: 10.1128/jvi.00885.
    >> Share

  64. LI Z, Ma Z, Han W, Chang C, et al
    Deletion of a 7-amino-acid region in the porcine epidemic diarrhea virus envelope protein induces higher type I and III interferon responses and results in attenuation in vivo.
    J Virol. 2023 Sep 8:e0084723. doi: 10.1128/jvi.00847.
    >> Share

  65. HAN P, Meng Y, Zhang D, Xu Z, et al
    Structural basis of white-tailed deer, Odocoileus virginianus, ACE2 recognizing all the SARS-CoV-2 variants of concern with high affinity.
    J Virol. 2023 Sep 7:e0050523. doi: 10.1128/jvi.00505.
    >> Share

  66. CASE JB, Scheaffer SM, Darling TL, Bricker TL, et al
    Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    J Virol. 2023 Sep 7:e0062823. doi: 10.1128/jvi.00628.
    >> Share

  67. LIU Y, Chen D, Wang Y, Li X, et al
    Characterization of CCoV-HuPn-2018 spike protein-mediated viral entry.
    J Virol. 2023 Sep 7:e0060123. doi: 10.1128/jvi.00601.
    >> Share

  68. DANIELS A, Fletcher S, Kerr HEM, Kratzel A, et al
    One for all-human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses.
    J Virol. 2023 Sep 5:e0055523. doi: 10.1128/jvi.00555.
    >> Share

  69. GUO H, Li A, Dong TY, Si HR, et al
    Isolation of ACE2-dependent and -independent sarbecoviruses from Chinese horseshoe bats.
    J Virol. 2023 Sep 1:e0039523. doi: 10.1128/jvi.00395.
    >> Share

    August 2023
  70. LIN HF, Liu MQ, Jiang RD, Gong QC, et al
    Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
    J Virol. 2023 Aug 21:e0079023. doi: 10.1128/jvi.00790.
    >> Share

  71. LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
    A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
    J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
    >> Share

  72. JIN H, Cheng L, Gong Y, Zhu Y, et al
    Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
    >> Share

  73. ZHANG W, Shi K, Geng Q, Herbst M, et al
    Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
    J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
    >> Share

  74. LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al
    Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
    J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684.
    >> Share

  75. MYKYTYN AZ, Breugem TI, Geurts MH, Beumer J, et al
    SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
    J Virol. 2023 Aug 9:e0085123. doi: 10.1128/jvi.00851.
    >> Share

    July 2023
  76. SHARMA M, Chakravarty D, Hussain A, Zalavadia A, et al
    Ifit2 restricts murine coronavirus spread to the spinal cord white matter and its associated myelin pathology.
    J Virol. 2023 Jul 28:e0074923. doi: 10.1128/jvi.00749.
    >> Share

  77. JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al
    Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
    J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596.
    >> Share

    June 2023
  78. YANG X, Duan H, Liu X, Zhang X, et al
    Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
    J Virol. 2023 Jun 27:e0061023. doi: 10.1128/jvi.00610.
    >> Share

  79. TERASAKI K, Narayanan K, Makino S
    Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
    J Virol. 2023 Jun 27:e0065923. doi: 10.1128/jvi.00659.
    >> Share

  80. KRISTEN-BURMANN C, Rogger P, Veiga IB, Riebesehl S, et al
    Reverse Genetic Assessment of the Roles Played by the Spike Protein and ORF3 in Porcine Epidemic Diarrhea Virus Pathogenicity.
    J Virol. 2023 Jun 26:e0196422. doi: 10.1128/jvi.01964.
    >> Share

  81. LI A, Zhang B, Zhao K, Yin Z, et al
    SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
    J Virol. 2023 Jun 22:e0051223. doi: 10.1128/jvi.00512.
    >> Share

  82. GOFFIN E, Du X, Hemmi S, Machiels B, et al
    A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
    J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135.
    >> Share

  83. ZHANG S, Zhang S, Hou Y, Huang Y, et al
    Porcine Deltacoronavirus Infection Disrupts the Intestinal Mucosal Barrier and Inhibits Intestinal Stem Cell Differentiation to Goblet Cells via the Notch Signaling Pathway.
    J Virol. 2023 Jun 8:e0068923. doi: 10.1128/jvi.00689.
    >> Share

    May 2023
  84. HE H, Wang W, Li L, Zhang X, et al
    Activation of the NLRP1 Inflammasome and Its Role in Transmissible Gastroenteritis Coronavirus Infection.
    J Virol. 2023 May 31:e0058923. doi: 10.1128/jvi.00589.
    >> Share

  85. ZHOU C, Liu Y, Wei Q, Chen Y, et al
    HSPA5 Promotes Attachment and Internalization of Porcine Epidemic Diarrhea Virus through Interaction with the Spike Protein and the Endo-/Lysosomal Pathway.
    J Virol. 2023 May 24:e0054923. doi: 10.1128/jvi.00549.
    >> Share

  86. SLANINA H, Madhugiri R, Wenk K, Reinke T, et al
    Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
    J Virol. 2023 May 18:e0046523. doi: 10.1128/jvi.00465.
    >> Share

  87. JIANG H, Joshi A, Gan T, Janowski AB, et al
    The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
    J Virol. 2023 May 18:e0063523. doi: 10.1128/jvi.00635.
    >> Share

  88. ISHIMARU H, Nishimura M, Tjan LH, Sutandhio S, et al
    Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
    J Virol. 2023 May 16:e0028623. doi: 10.1128/jvi.00286.
    >> Share

  89. SENGAR A, Cervantes M, Bondalapati ST, Hess T, et al
    Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
    J Virol. 2023 May 3:e0199222. doi: 10.1128/jvi.01992.
    >> Share

  90. LI Z, Duan P, Qiu R, Fang L, et al
    HDAC6 Degrades nsp8 of Porcine Deltacoronavirus through Deacetylation and Ubiquitination to Inhibit Viral Replication.
    J Virol. 2023 May 3:e0037523. doi: 10.1128/jvi.00375.
    >> Share

  91. GUO X, Feng Y, Zhao X, Qiao S, et al
    Coronavirus Porcine Epidemic Diarrhea Virus Utilizes Chemokine Interleukin-8 to Facilitate Viral Replication by Regulating Ca(2+) Flux.
    J Virol. 2023 May 3:e0029223. doi: 10.1128/jvi.00292.
    >> Share

    April 2023
  92. YOU R, Liu K, Huang M, Tang L, et al
    Identification and Comparison of the Sialic Acid-Binding Domain Characteristics of Avian Coronavirus Infectious Bronchitis Virus Spike Protein.
    J Virol. 2023 Apr 25:e0048923. doi: 10.1128/jvi.00489.
    >> Share

  93. SPECK P, Mackenzie J, Bull RA, Slobedman B, et al
    Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
    J Virol. 2023 Apr 25:e0045123. doi: 10.1128/jvi.00451.
    >> Share

  94. KETTUNEN P, Lesnikova A, Rasanen N, Ojha R, et al
    SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
    J Virol. 2023 Apr 11:e0014423. doi: 10.1128/jvi.00144.
    >> Share

    March 2023
  95. JI Z, Dong H, Jiao R, Zhu X, et al
    The TGEV Membrane Protein Interacts with HSC70 To Direct Virus Internalization through Clathrin-Mediated Endocytosis.
    J Virol. 2023 Mar 28:e0012823. doi: 10.1128/jvi.00128.
    >> Share

  96. CHEN XN, Liang YF, Weng ZJ, Quan WP, et al
    Porcine Enteric Alphacoronavirus Entry through Multiple Pathways (Caveolae, Clathrin, and Macropinocytosis) Requires Rab GTPases for Endosomal Transport.
    J Virol. 2023 Mar 28:e0021023. doi: 10.1128/jvi.00210.
    >> Share

  97. ALWINE JC, Casadevall A, Enquist LW, Goodrum FD, et al
    A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses.
    J Virol. 2023 Mar 10:e0036523. doi: 10.1128/jvi.00365.
    >> Share

  98. WANG X, Wang W, Wang T, Wang J, et al
    SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
    J Virol. 2023 Mar 6:e0001123. doi: 10.1128/jvi.00011.
    >> Share

  99. DUAN Y, Yuan C, Suo X, Li Y, et al
    Bat-Origin Swine Acute Diarrhea Syndrome Coronavirus Is Lethal to Neonatal Mice.
    J Virol. 2023 Mar 6:e0019023. doi: 10.1128/jvi.00190.
    >> Share

  100. MOLS VC, Lamers MM, Leijten LM, Breugem TI, et al
    Intestinal Tropism of a Betacoronavirus (Merbecovirus) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host.
    J Virol. 2023 Mar 1:e0009923. doi: 10.1128/jvi.00099.
    >> Share

    February 2023
  101. FROLOV I, Agback T, Palchevska O, Dominguez F, et al
    All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein.
    J Virol. 2023 Feb 27:e0186522. doi: 10.1128/jvi.01865.
    >> Share

  102. QIN W, Qi X, Xie Y, Wang H, et al
    LncRNA446 Regulates Tight Junctions by Inhibiting the Ubiquitinated Degradation of Alix after Porcine Epidemic Diarrhea Virus Infection.
    J Virol. 2023 Feb 15:e0188422. doi: 10.1128/jvi.01884.
    >> Share

  103. ZHANG L, Hom N, Ojha A, Lovendahl KN, et al
    Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions.
    J Virol. 2023 Feb 15:e0165022. doi: 10.1128/jvi.01650.
    >> Share

  104. WANG X, Wen Z, Cao H, Luo J, et al
    Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
    J Virol. 2023 Feb 13:e0161122. doi: 10.1128/jvi.01611.
    >> Share

  105. KEEP S, Dowgier G, Lulla V, Britton P, et al
    Deletion of the s2m RNA Structure in the Avian Coronavirus Infectious Bronchitis Virus and Human Astrovirus Results in Sequence Insertions.
    J Virol. 2023 Feb 13:e0003823. doi: 10.1128/jvi.00038.
    >> Share

  106. AMANAT F, Clark J, Carreno JM, Strohmeier S, et al
    Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
    J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664.
    >> Share

  107. ZHOU H, Yan Y, Gao J, Ma M, et al
    Heterogeneous Nuclear Protein U Degraded the m(6)A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication.
    J Virol. 2023 Feb 8:e0175122. doi: 10.1128/jvi.01751.
    >> Share

  108. LIN J, Law R, Korosec CS, Zhou C, et al
    Erratum for Lin et al., "Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity".
    J Virol. 2023 Feb 7:e0008023. doi: 10.1128/jvi.00080.
    >> Share

  109. BEI C, Zhang C, Wu H, Feng H, et al
    DDX3X Is Hijacked by Snakehead Vesiculovirus Phosphoprotein To Facilitate Virus Replication via Stabilization of the Phosphoprotein.
    J Virol. 2023 Feb 6:e0003523. doi: 10.1128/jvi.00035.
    >> Share

  110. SCHINDEWOLF C, Lokugamage K, Vu MN, Johnson BA, et al
    SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
    J Virol. 2023 Feb 1:e0153222. doi: 10.1128/jvi.01532.
    >> Share

    January 2023
  111. ZHAI X, Kong N, Wang C, Qin W, et al
    PRPF19 Limits Porcine Epidemic Diarrhea Virus Replication through Targeting and Degrading Viral Capsid Protein.
    J Virol. 2023;97:e0161422.
    >> Share

  112. GOODRUM F, Lowen A, Lakdawala S, Alwine J, et al
    Virology under the Microscope-a Call for Rational Discourse.
    J Virol. 2023 Jan 26:e0008923. doi: 10.1128/jvi.00089.
    >> Share

  113. LIU MQ, Lin HF, Li J, Chen Y, et al
    A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
    J Virol. 2023 Jan 23:e0171922. doi: 10.1128/jvi.01719.
    >> Share

  114. RAJAGOPALA SV, Strickland BA, Pakala SB, Kimura KS, et al
    Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    J Virol. 2023 Jan 19:e0147822. doi: 10.1128/jvi.01478.
    >> Share

  115. LIANG QZ, Wang B, Ji CM, Hu F, et al
    Chicken or Porcine Aminopeptidase N Mediates Cellular Entry of Pseudoviruses Carrying Spike Glycoprotein from the Avian Deltacoronaviruses HKU11, HKU13, and HKU17.
    J Virol. 2023 Jan 19:e0194722. doi: 10.1128/jvi.01947.
    >> Share

  116. MA J, Liu X, Zhou M, Chen P, et al
    A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    J Virol. 2023 Jan 18:e0168422. doi: 10.1128/jvi.01684.
    >> Share

  117. SHIWA-SUDO N, Sakai Y, Iwata-Yoshikawa N, Watanabe S, et al
    Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    J Virol. 2023 Jan 12:e0136622. doi: 10.1128/jvi.01366.
    >> Share

    December 2022
  118. CHANG P, Lukosaityte D, Sealy JE, Rijal P, et al
    Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.
    J Virol. 2022 Dec 21:e0143122. doi: 10.1128/jvi.01431.
    >> Share

  119. CHEN Y, Wu Y, Chen S, Zhan Q, et al
    Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
    J Virol. 2022 Dec 5:e0124522. doi: 10.1128/jvi.01245.
    >> Share

  120. WANG X, Jin Q, Xiao W, Fang P, et al
    Genome-Wide CRISPR/Cas9 Screen Reveals a Role for SLC35A1 in the Adsorption of Porcine Deltacoronavirus.
    J Virol. 2022 Dec 1:e0162622. doi: 10.1128/jvi.01626.
    >> Share

    November 2022
  121. CHOI SSA, Chan HH, Chan CM, Wang X, et al
    Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry.
    J Virol. 2022 Nov 30:e0141822. doi: 10.1128/jvi.01418.
    >> Share

  122. BELSER JA, Sun X, Kieran TJ, Brock N, et al
    Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
    J Virol. 2022 Nov 30:e0140322. doi: 10.1128/jvi.01403.
    >> Share

  123. XUE M, Wang W, He H, Li L, et al
    Different Mechanisms Are Utilized by Coronavirus Transmissible Gastroenteritis Virus To Regulate Interferon Lambda 1 and Interferon Lambda 3 Production.
    J Virol. 2022 Nov 30:e0138822. doi: 10.1128/jvi.01388.
    >> Share

  124. NIU Z, Xu S, Zhang Y, Kan Z, et al
    Transmissible Gastroenteritis Virus Nucleocapsid Protein Interacts with Na(+)/H(+) Exchanger 3 To Reduce Na(+)/H(+) Exchanger Activity and Promote Piglet Diarrhea.
    J Virol. 2022;96:e0147322.
    >> Share

  125. TAN TS, Toyoda M, Ode H, Barabona G, et al
    Erratum for Tan et al., "Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike".
    J Virol. 2022 Nov 21:e0173722. doi: 10.1128/jvi.01737.
    >> Share

  126. LISTA MJ, Winstone H, Wilson HD, Dyer A, et al
    The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
    J Virol. 2022 Nov 9:e0125022. doi: 10.1128/jvi.01250.
    >> Share

  127. WANG X, Kerkmann L, Hetzel M, Windmann S, et al
    Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
    J Virol. 2022 Nov 7:e0113322. doi: 10.1128/jvi.01133.
    >> Share

  128. CZERKIES M, Kochanczyk M, Korwek Z, Prus W, et al
    Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
    J Virol. 2022 Nov 3:e0134122. doi: 10.1128/jvi.01341.
    >> Share

  129. QIN W, Kong N, Wang C, Dong S, et al
    hnRNP K Degrades Viral Nucleocapsid Protein and Induces Type I IFN Production to Inhibit Porcine Epidemic Diarrhea Virus Replication.
    J Virol. 2022 Nov 1:e0155522. doi: 10.1128/jvi.01555.
    >> Share

    October 2022
  130. LAU SKP, Poon RWS, Wong BHL, Wang M, et al
    Retraction for Lau et al., "Coexistence of Different Genotypes in the Same Bat and Serological Characterization of Rousettus Bat Coronavirus HKU9 Belonging to a Novel Betacoronavirus Subgroup".
    J Virol. 2022 Oct 31:e0148522. doi: 10.1128/jvi.01485.
    >> Share

  131. WOO PCY, Lau SKP, Lam CSF, Tsang AKL, et al
    Retraction for Woo et al., "Discovery of a Novel Bottlenose Dolphin Coronavirus Reveals a Distinct Species of Marine Mammal Coronavirus in Gammacoronavirus".
    J Virol. 2022 Oct 31:e0150322. doi: 10.1128/jvi.01503.
    >> Share

  132. SIU KL, Yeung ML, Kok KH, Yuen KS, et al
    Retraction for Siu et al., "Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response".
    J Virol. 2022 Oct 31:e0150422. doi: 10.1128/jvi.01504.
    >> Share

  133. SACCO MT, Bland KM, Horner SM
    WTAP Targets the METTL3 m(6)A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
    J Virol. 2022 Oct 31:e0099722. doi: 10.1128/jvi.00997.
    >> Share

  134. TAN TS, Toyoda M, Ode H, Barabona G, et al
    Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike.
    J Virol. 2022 Oct 10:e0116222. doi: 10.1128/jvi.01162.
    >> Share

    September 2022
  135. CHEN M, Wang MH, Shen XG, Liu H, et al
    Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner.
    J Virol. 2022 Sep 29:e0131822. doi: 10.1128/jvi.01318.
    >> Share

  136. YANG N, Zhang Y, Fu Y, Li Y, et al
    Transmissible Gastroenteritis Virus Infection Promotes the Self-Renewal of Porcine Intestinal Stem Cells via Wnt/beta-Catenin Pathway.
    J Virol. 2022;96:e0096222.
    >> Share

  137. GELLENONCOURT S, Saunders N, Robinot R, Auguste L, et al
    The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    J Virol. 2022 Sep 19:e0130122. doi: 10.1128/jvi.01301.
    >> Share

  138. AO Z, Ouyang MJ, Olukitibi TA, Warner B, et al
    A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    J Virol. 2022 Sep 7:e0133722. doi: 10.1128/jvi.01337.
    >> Share

    August 2022
  139. ZHANG C, Cui H, Guo Z, Chen Z, et al
    SARS-CoV-2 Virus Culture, Genomic and Subgenomic RNA Load, and Rapid Antigen Test in Experimentally Infected Syrian Hamsters.
    J Virol. 2022 Aug 30:e0103422. doi: 10.1128/jvi.01034.
    >> Share

  140. FAN B, Peng Q, Song S, Shi D, et al
    Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.
    J Virol. 2022 Aug 29:e0102422. doi: 10.1128/jvi.01024.
    >> Share

  141. MARTINS M, do Nascimento GM, Nooruzzaman M, Yuan F, et al
    The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    J Virol. 2022 Aug 24:e0096122. doi: 10.1128/jvi.00961.
    >> Share

  142. SU C, He J, Han P, Bai B, et al
    Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
    J Virol. 2022 Aug 24:e0081422. doi: 10.1128/jvi.00814.
    >> Share

  143. KAZEMI S, Lopez-Munoz AD, Holly J, Jin L, et al
    Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
    J Virol. 2022 Aug 24:e0025622. doi: 10.1128/jvi.00256.
    >> Share

  144. JIAO Z, Yan Y, Chen Y, Wang G, et al
    Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
    J Virol. 2022 Aug 24:e0090722. doi: 10.1128/jvi.00907.
    >> Share

  145. NEERUKONDA SN, Wang R, Vassell R, Baha H, et al
    Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
    J Virol. 2022 Aug 24:e0114022. doi: 10.1128/jvi.01140.
    >> Share

  146. CHEN Y, Jiang RD, Wang Q, Luo Y, et al
    Lethal Swine Acute Diarrhea Syndrome Coronavirus Infection in Suckling Mice.
    J Virol. 2022 Aug 22:e0006522. doi: 10.1128/jvi.00065.
    >> Share

  147. ZHOU Y, Zheng R, Liu D, Liu S, et al
    UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
    J Virol. 2022 Aug 18:e0074122. doi: 10.1128/jvi.00741.
    >> Share

  148. GUPTA SL, Mantus G, Manning KE, Ellis M, et al
    Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
    J Virol. 2022 Aug 17:e0058222. doi: 10.1128/jvi.00582.
    >> Share

  149. KEEP S, Stevenson-Leggett P, Dowgier G, Foldes K, et al
    A Temperature-Sensitive Recombinant of Avian Coronavirus Infectious Bronchitis Virus Provides Complete Protection against Homologous Challenge.
    J Virol. 2022 Aug 16:e0110022. doi: 10.1128/jvi.01100.
    >> Share

  150. YUAN C, Suo X, Duan Y, Li X, et al
    Comprehensive Subcellular Localization of Swine Acute Diarrhea Syndrome Coronavirus Proteins.
    J Virol. 2022 Aug 16:e0077222. doi: 10.1128/jvi.00772.
    >> Share

  151. HAN Y, Bai X, Liu S, Zhu J, et al
    XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.
    J Virol. 2022 Aug 16:e0077422. doi: 10.1128/jvi.00774.
    >> Share

  152. SHI J, Zheng J, Tai W, Verma AK, et al
    A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 16:e0011822. doi: 10.1128/jvi.00118.
    >> Share

  153. UNDI RB, Larabee JL, Filiberti A, Ulahannan S, et al
    Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
    J Virol. 2022 Aug 9:e0096722. doi: 10.1128/jvi.00967.
    >> Share

  154. VETTER J, Papa G, Seyffert M, Gunasekera K, et al
    Rotavirus Spike Protein VP4 Mediates Viroplasm Assembly by Association to Actin Filaments.
    J Virol. 2022 Aug 8:e0107422. doi: 10.1128/jvi.01074.
    >> Share

  155. ANDERSON-DANIELS J, Gribble J, Denison M
    Proteolytic Processing of the Coronavirus Replicase Nonstructural Protein 14 Exonuclease Is Not Required for Virus Replication but Alters RNA Synthesis and Viral Fitness.
    J Virol. 2022 Aug 4:e0084122. doi: 10.1128/jvi.00841.
    >> Share

  156. ABDELNABI R, Foo CS, Kaptein SJF, Boudewijns R, et al
    A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 4:e0075822. doi: 10.1128/jvi.00758.
    >> Share

  157. CAMPAGNOLA G, Govindarajan V, Pelletier A, Canard B, et al
    The SARS-CoV nsp12 Polymerase Active Site Is Tuned for Large-Genome Replication.
    J Virol. 2022 Aug 4:e0067122. doi: 10.1128/jvi.00671.
    >> Share

  158. ZHAN W, Tian X, Zhang X, Xing S, et al
    Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    J Virol. 2022 Aug 4:e0048022. doi: 10.1128/jvi.00480.
    >> Share

  159. LI Z, Fang P, Duan P, Chen J, et al
    Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral Activity.
    J Virol. 2022 Aug 2:e0102722. doi: 10.1128/jvi.01027.
    >> Share

  160. YUAN M, Chen X, Zhu Y, Dong X, et al
    A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
    J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
    >> Share

    July 2022
  161. FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
    Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
    >> Share

  162. AKAISHI T, Horii A, Ishii T
    Sequence Exchange Involving Dozens of Consecutive Bases with External Origin in SARS-Related Coronaviruses.
    J Virol. 2022 Jul 20:e0100222. doi: 10.1128/jvi.01002.
    >> Share

  163. GUO H, Li A, Lin HF, Liu MQ, et al
    The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint.
    J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
    >> Share

  164. MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
    Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
    J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
    >> Share

  165. DONG S, Kong N, Wang C, Li Y, et al
    FUBP3 Degrades the Porcine Epidemic Diarrhea Virus Nucleocapsid Protein and Induces the Production of Type I Interferon.
    J Virol. 2022;96:e0061822.
    >> Share

  166. PUSNIK J, Konig J, Mai K, Richter E, et al
    Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
    J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
    >> Share

  167. CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
    A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
    >> Share

  168. OISHI K, Horiuchi S, Minkoff JM, tenOever BR, et al
    The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    J Virol. 2022 Jul 12:e0076522. doi: 10.1128/jvi.00765.
    >> Share

  169. AICHER SM, Streicher F, Chazal M, Planas D, et al
    Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells.
    J Virol. 2022 Jul 5:e0060822. doi: 10.1128/jvi.00608.
    >> Share

  170. XING N, Wang Z, Wang J, Nascimento M, et al
    Engineering and Characterization of Avian Coronavirus Mutants Expressing Fluorescent Reporter Proteins from the Replicase Gene.
    J Virol. 2022 Jul 5:e0065322. doi: 10.1128/jvi.00653.
    >> Share

    June 2022
  171. VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
    J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
    >> Share

  172. JIANG C, Li L, Xue M, Zhao L, et al
    Long-Term Expanding Porcine Airway Organoids Provide Insights into the Pathogenesis and Innate Immunity of Porcine Respiratory Coronavirus Infection.
    J Virol. 2022 Jun 28:e0073822. doi: 10.1128/jvi.00738.
    >> Share

  173. DIEBOLD O, Gonzalez V, Venditti L, Sharp C, et al
    Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes.
    J Virol. 2022 Jun 27:e0048822. doi: 10.1128/jvi.00488.
    >> Share

  174. YUAN C, Zhang P, Liu P, Li Y, et al
    A Novel Pathway for Porcine Epidemic Diarrhea Virus Transmission from Sows to Neonatal Piglets Mediated by Colostrum.
    J Virol. 2022 Jun 27:e0047722. doi: 10.1128/jvi.00477.
    >> Share

  175. BI W, Chen G, Dang B
    Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
    J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
    >> Share

  176. CHAN CE, Ng CG, Lim AP, Seah SL, et al
    The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
    J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
    >> Share

  177. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    >> Share

  178. SUN C, Yuan RY, Xie C, Sun JF, et al
    Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
    J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
    >> Share

  179. LAVIE M, Dubuisson J, Belouzard S
    SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
    >> Share

  180. SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
    A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
    J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
    >> Share

  181. ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
    Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".
    J Virol. 2022 Jun 6:e0074522. doi: 10.1128/jvi.00745.
    >> Share

  182. CHEN X, Li J, Yang L, Zhou Y, et al
    Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
    J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
    >> Share

  183. LIU H, Bai Y, Zhang X, Gao T, et al
    SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.
    J Virol. 2022 Jun 2:e0041222. doi: 10.1128/jvi.00412.
    >> Share

    May 2022
  184. ZHAO J, Feng D, Zhao Y, Huang M, et al
    Role of Stress Granules in Suppressing Viral Replication by the Infectious Bronchitis Virus Endoribonuclease.
    J Virol. 2022 May 31:e0068622. doi: 10.1128/jvi.00686.
    >> Share

  185. DIJKMAN R, Verma AK, Selvaraj M, Ghimire R, et al
    Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice.
    J Virol. 2022 May 19:e0036422. doi: 10.1128/jvi.00364.
    >> Share

  186. NIU X, Kong F, Xu J, Liu M, et al
    Mutations in Porcine Epidemic Diarrhea Virus nsp1 Cause Increased Viral Sensitivity to Host Interferon Responses and Attenuation In Vivo.
    J Virol. 2022 May 18:e0046922. doi: 10.1128/jvi.00469.
    >> Share

  187. NCHIOUA R, Schundner A, Kmiec D, Prelli Bozzo C, et al
    SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
    J Virol. 2022 May 11:e0059422. doi: 10.1128/jvi.00594.
    >> Share

  188. DONG S, Kong N, Zhang Y, Li Y, et al
    TARDBP Inhibits Porcine Epidemic Diarrhea Virus Replication through Degrading Viral Nucleocapsid Protein and Activating Type I Interferon Signaling.
    J Virol. 2022 May 2:e0007022. doi: 10.1128/jvi.00070.
    >> Share

    April 2022
  189. ZHANG J, Yuan S, Peng Q, Ding Z, et al
    Porcine Epidemic Diarrhea Virus nsp7 Inhibits Interferon-Induced JAK-STAT Signaling through Sequestering the Interaction between KPNA1 and STAT1.
    J Virol. 2022 Apr 20:e0040022. doi: 10.1128/jvi.00400.
    >> Share

  190. LI J, Li Y, Liu P, Wang X, et al
    Porcine Epidemic Diarrhea Virus Infection Disrupts the Nasal Endothelial Barrier To Favor Viral Dissemination.
    J Virol. 2022 Apr 18:e0038022. doi: 10.1128/jvi.00380.
    >> Share

  191. ZHENG XS, Wang Q, Min J, Shen XR, et al
    Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
    J Virol. 2022 Apr 14:e0003822. doi: 10.1128/jvi.00038.
    >> Share

  192. AGUILAR EG, Paniccia G, Adura C, Singer ZS, et al
    Sindbis Macrodomain Poly-ADP-Ribose Hydrolase Activity Is Important for Viral RNA Synthesis.
    J Virol. 2022;96:e0151621.
    >> Share

  193. DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
    Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
    >> Share

  194. LANGLEY WA, Wieland A, Ahmed H, Rasheed MAU, et al
    Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.
    J Virol. 2022 Apr 11:e0002622. doi: 10.1128/jvi.00026.
    >> Share

  195. CHEN J, Li Z, Guo J, Xu S, et al
    SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
    J Virol. 2022 Apr 7:e0003722. doi: 10.1128/jvi.00037.
    >> Share

  196. FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
    The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
    J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
    >> Share

  197. LI J, Lin C, Zhou X, Zhong F, et al
    Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
    J Virol. 2022 Apr 7:e0201321. doi: 10.1128/jvi.02013.
    >> Share

  198. KLASSE PJ, Moore JP
    Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
    J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
    >> Share

    March 2022
  199. HANCOCK TJ, Hickman P, Kazerooni N, Kennedy M, et al
    Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain.
    J Virol. 2022 Mar 30:e0025022. doi: 10.1128/jvi.00250.
    >> Share

  200. ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
    Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    J Virol. 2022 Mar 28:e0012822. doi: 10.1128/jvi.00128.
    >> Share

  201. GENG Q, Shi K, Ye G, Zhang W, et al
    Structural Basis for Human Receptor Recognition by SARS-CoV Omicron Variant BA.1.
    J Virol. 2022 Mar 28:e0024922. doi: 10.1128/jvi.00249.
    >> Share

  202. LIU MQ, Jiang RD, Guo J, Chen Y, et al
    Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
    >> Share

  203. XIANG J, Lu M, Shi M, Cheng X, et al
    Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
    >> Share

  204. LIU X, Yin L, Xue M, Chen J, et al
    Coronavirus Porcine Deltacoronavirus Upregulates MHC Class I Expression through RIG-I/IRF1-Mediated NLRC5 Induction.
    J Virol. 2022 Mar 21:e0015822. doi: 10.1128/jvi.00158.
    >> Share

  205. REINECKE B, Frericks N, Lauber C, Dinkelborg K, et al
    The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
    J Virol. 2022 Mar 17:e0199521. doi: 10.1128/jvi.01995.
    >> Share

  206. BERKHOUT B, Herrera-Carrillo E
    SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
    J Virol. 2022 Mar 16:e0009022. doi: 10.1128/jvi.00090.
    >> Share

  207. GAO J, Tang YD, Hu W, Zheng C, et al
    When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2.
    J Virol. 2022 Mar 16:e0013622. doi: 10.1128/jvi.00136.
    >> Share

  208. METZ-ZUMARAN C, Kee C, Doldan P, Guo C, et al
    Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    J Virol. 2022 Mar 9:e0170521. doi: 10.1128/jvi.01705.
    >> Share

  209. LI M, Wu Y, Chen J, Shi H, et al
    Innate Immune Evasion of Porcine Epidemic Diarrhea Virus through Degradation of the FBXW7 Protein via the Ubiquitin-Proteasome Pathway.
    J Virol. 2022;96:e0088921.
    >> Share

    February 2022
  210. JUNG C, Kmiec D, Koepke L, Zech F, et al
    Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?
    J Virol. 2022 Feb 28:jvi0207721. doi: 10.1128/jvi.02077.
    >> Share

  211. KIM EH, Nguyen TQ, Casel MAB, Rollon R, et al
    Coinfection of SARS-CoV-2 and Influenza A virus increased disease severity, impaired neutralizing antibody, and CD4+ T cell responses.
    J Virol. 2022 Feb 2:jvi0187321. doi: 10.1128/jvi.01873.
    >> Share

  212. ARIUMI Y
    Host cellular RNA helicases regulate SARS-CoV-2 infection.
    J Virol. 2022 Feb 2:jvi0000222. doi: 10.1128/jvi.00002.
    >> Share

    January 2022
  213. LIU S, Chou CK, Wu WW, Luan B, et al
    Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
    J Virol. 2022 Jan 26:jvi0221621. doi: 10.1128/jvi.02216.
    >> Share

  214. WONG TY, Horspool AM, Russ BP, Ye C, et al
    Evaluating antibody mediated protection against Alpha, Beta, and Delta SARS-CoV-2 variants of concern in K18-hACE2 transgenic mice.
    J Virol. 2022 Jan 26:jvi0218421. doi: 10.1128/jvi.02184.
    >> Share

  215. CHEN W, Huang C, Shi Y, Li N, et al
    Investigation of the Crosstalk between GRP78/PERK/ATF-4 Signaling Pathway and Renal Apoptosis Induced by Nephropathogenic Infectious Bronchitis Virus Infection.
    J Virol. 2022;96:e0142921.
    >> Share

  216. DU S, Xu W, Wang Y, Li L, et al
    The "LLQY" motif on SARS-CoV-2 spike protein affects S incorporation into virus particles.
    J Virol. 2022 Jan 19:jvi0189721. doi: 10.1128/jvi.01897.
    >> Share

  217. KEEP S, Stevenson-Leggett P, Dowgier G, Everest H, et al
    Identification of amino acids within non-structural proteins 10 and 14 of the avian coronavirus infectious bronchitis virus that result in attenuation in vivo and in ovo.
    J Virol. 2022 Jan 19:jvi0205921. doi: 10.1128/jvi.02059.
    >> Share

  218. CHAUDHRY MZ, Eschke K, Hoffmann M, Grashoff M, et al
    Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    J Virol. 2022 Jan 12:jvi0218621. doi: 10.1128/jvi.02186.
    >> Share


  219. Articles of Significant Interest in This Issue.
    J Virol. 2022;96:e0186421.
    >> Share

  220. LI S, Liu S, Chen RA, Huang M, et al
    Activation of the MKK3-p38-MK2-ZFP36 axis by coronavirus infection restricts the upregulation of AU-rich element-containing transcripts in proinflammatory response.
    J Virol. 2022 Jan 5:jvi0208621. doi: 10.1128/jvi.02086.
    >> Share

    December 2021
  221. HUANG Y, Skarlupka AL, Jang H, Blas-Machado U, et al
    SARS-CoV-2 and Influenza A virus Co-infections in Ferrets.
    J Virol. 2021 Dec 22:JVI0179121. doi: 10.1128/JVI.01791.
    >> Share

  222. OLIVARRIA GM, Cheng Y, Furman S, Pachow C, et al
    Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
    J Virol. 2021 Dec 22:jvi0196921. doi: 10.1128/jvi.01969.
    >> Share

  223. ETTICH J, Werner J, Weitz HT, Mueller E, et al
    A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
    J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
    >> Share

  224. NELSON M, O'Brien LM, Davies C, Keyser E, et al
    Comparison of experimental MERS-CoV infection acquired by three individual routes of infection in the common marmoset.
    J Virol. 2021 Dec 15:JVI0173921. doi: 10.1128/JVI.01739.
    >> Share

  225. CAO K, Wang X, Peng H, Ding L, et al
    A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
    J Virol. 2021 Dec 15:JVI0157821. doi: 10.1128/JVI.01578.
    >> Share

  226. SHI J, Shi Y, Xiu R, Wang G, et al
    Identification of a novel neutralizing epitope on the N-terminal domain of the HCoV-229E spike protein.
    J Virol. 2021 Dec 15:JVI0195521. doi: 10.1128/JVI.01955.
    >> Share

  227. ZHANG Y, Yan Q, Luo K, He P, et al
    Analysis of B cell receptor repertoires reveals key signatures of systemic B cell response after SARS-CoV-2 infection.
    J Virol. 2021 Dec 8:JVI0160021. doi: 10.1128/JVI.01600.
    >> Share

  228. MALICOAT J, Manivasagam S, Zuniga S, Sola I, et al
    Development of a Single-cycle Infectious SARS-CoV-2 Virus Replicon Particle System for use in BSL2 Laboratories.
    J Virol. 2021 Dec 1:JVI0183721. doi: 10.1128/JVI.01837.
    >> Share

    November 2021
  229. TAKAMATSU Y, Imai M, Maeda K, Nakajima N, et al
    Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
    J Virol. 2021 Nov 24:JVI0155121. doi: 10.1128/JVI.01551.
    >> Share

  230. ZHANG S, Go EP, Ding H, Anang S, et al
    Glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
    J Virol. 2021 Nov 24:JVI0162621. doi: 10.1128/JVI.01626.
    >> Share

  231. UJIKE M, Etoh Y, Urushiyama N, Taguchi F, et al
    Reverse Genetics with a Full-length Infectious cDNA Clone of Bovine Torovirus.
    J Virol. 2021 Nov 24:JVI0156121. doi: 10.1128/JVI.01561.
    >> Share

  232. MARTINS M, Fernandes MHV, Joshi LR, Diel DG, et al
    Age-related susceptibility of ferrets to SARS-CoV-2 infection.
    J Virol. 2021 Nov 24:JVI0145521. doi: 10.1128/JVI.01455.
    >> Share

  233. BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
    Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
    >> Share

  234. LI Y, Jin Y, Kuang L, Luo Z, et al
    The N-terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus.
    J Virol. 2021 Nov 24:JVI0184221. doi: 10.1128/JVI.01842.
    >> Share

  235. LIU Y, Wang B, Liang QZ, Shi FS, et al
    Roles of Two Major Domains of the Porcine Deltacoronavirus S1 Subunit in Receptor Binding and Neutralization.
    J Virol. 2021;95:e0111821.
    >> Share

  236. HEMSATH JR, Liaci AM, Rubin JD, Parrett BJ, et al
    Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26).
    J Virol. 2021 Nov 17:JVI0082621. doi: 10.1128/JVI.00826.
    >> Share

  237. BASU A, Penumutchu S, Nguyen K, Mbonye U, et al
    A structurally conserved RNA element within SARS-CoV-2 ORF1a RNA and S mRNA regulates translation in response to viral S protein-induced signaling in human lung cells.
    J Virol. 2021 Nov 10:JVI0167821. doi: 10.1128/JVI.01678.
    >> Share

  238. LAMARCA AP, de Almeida LGP, da Silva Francisco Junior R, Cavalcante L, et al
    Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil.
    J Virol. 2021 Nov 3:JVI0122821. doi: 10.1128/JVI.01228.
    >> Share

    October 2021
  239. YU J, Collins ND, Mercado NB, McMahan K, et al
    Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
    >> Share

  240. SHARMA L, Peng X, Qing H, Hilliard BK, et al
    Distinct Roles of Type I and Type III Interferons During a Native Murine beta Coronavirus Lung Infection.
    J Virol. 2021 Oct 27:JVI0124121. doi: 10.1128/JVI.01241.
    >> Share

  241. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Reply to Grigoriev et al., "Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs 1 of Non-coding RNA?"
    J Virol. 2021 Oct 27:JVI0169021. doi: 10.1128/JVI.01690.
    >> Share

  242. GRIGORIEV A, Kelley JJ, Guan L
    Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs of Non-coding RNA?
    J Virol. 2021 Oct 27:JVI0146221. doi: 10.1128/JVI.01462.
    >> Share

  243. SIDDIQ MM, Chan AT, Miorin L, Yadaw AS, et al
    Functional Effects of Cardiomyocyte Injury in COVID-19.
    J Virol. 2021 Oct 20:JVI0106321. doi: 10.1128/JVI.01063.
    >> Share

  244. WINKLER ES, Chen RE, Alam F, Yildiz S, et al
    SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice.
    J Virol. 2021 Oct 20:JVI0151121. doi: 10.1128/JVI.01511.
    >> Share

  245. DONG W, Mead H, Tian L, Park JG, et al
    The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.
    J Virol. 2021 Oct 20:JVI0096421. doi: 10.1128/JVI.00964.
    >> Share

  246. LUSVARGHI S, Wang W, Herrup R, Neerukonda SN, et al
    Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects.
    J Virol. 2021 Oct 20:JVI0111021. doi: 10.1128/JVI.01110.
    >> Share

  247. REN W, Zhu Y, Lan J, Chen H, et al
    Susceptibilities of human ACE2 genetic variants in coronavirus infection.
    J Virol. 2021 Oct 20:JVI0149221. doi: 10.1128/JVI.01492.
    >> Share

  248. CHU HF, Cheng SC, Sun CY, Chou CY, et al
    Structural and Biochemical Characterization of PEDV Papain-like Protease 2.
    J Virol. 2021 Oct 13:JVI0137221. doi: 10.1128/JVI.01372.
    >> Share

  249. SHI J, Li Z, Xu R, Zhang J, et al
    The PERK/PKR-eIF2alpha pathway negatively regulates porcine hemagglutinating encephalomyelitis virus replication by attenuating global protein translation and facilitating stress granule formation.
    J Virol. 2021 Oct 13:JVI0169521. doi: 10.1128/JVI.01695.
    >> Share

  250. NAVARATNARAJAH CK, Pease DR, Halfmann P, Taye B, et al
    Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition.
    J Virol. 2021 Oct 6:JVI0136821. doi: 10.1128/JVI.01368.
    >> Share

    September 2021
  251. SHUE B, Chiramel AI, Cerikan B, To TH, et al
    Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication.
    J Virol. 2021 Sep 29:JVI0059621. doi: 10.1128/JVI.00596.
    >> Share

  252. SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
    Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
    J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
    >> Share

  253. KIM YJ, Witwit H, Cubitt B, de la Torre JC, et al
    Inhibitors of anti-apoptotic Bcl-2 family proteins exhibit potent and broad-spectrum anti-mammarenavirus activity via cell cycle arrest at G0/G1 phase.
    J Virol. 2021 Sep 29:JVI0139921. doi: 10.1128/JVI.01399.
    >> Share

  254. FANG P, Zhang J, Zhang H, Xia S, et al
    Porcine deltacoronavirus enters porcine IPI-2I intestinal epithelial cells via macropinocytosis and clathrin-mediated endocytosis dependent on pH and dynamin.
    J Virol. 2021 Sep 29:JVI0134521. doi: 10.1128/JVI.01345.
    >> Share

  255. ZHANG Y, Gao H, Hu X, Wang Q, et al
    Structure-based discovery and structural basis of a novel broad-spectrum natural product against main protease of coronavirus.
    J Virol. 2021 Sep 29:JVI0125321. doi: 10.1128/JVI.01253.
    >> Share

  256. PELZ L, Rudiger D, Dogra T, Alnaji FG, et al
    Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy.
    J Virol. 2021 Sep 22:JVI0117421. doi: 10.1128/JVI.01174.
    >> Share

  257. ACHARYA A, Pandey K, Thurman M, Klug E, et al
    Discovery and evaluation of entry inhibitors for SARS-CoV-2 and its emerging variants.
    J Virol. 2021 Sep 22:JVI0143721. doi: 10.1128/JVI.01437.
    >> Share

  258. SHANG C, Zhuang X, Zhang H, Li Y, et al
    Inhibition of autophagy suppresses SARS-CoV-2 replication and ameliorates pneumonia in hACE2 transgenic mice and xenografted human lung tissues.
    J Virol. 2021 Sep 22:JVI0153721. doi: 10.1128/JVI.01537.
    >> Share

  259. QIAN Y, Lei T, Patel PS, Lee CH, et al
    Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.
    J Virol. 2021 Sep 22:JVI0139621. doi: 10.1128/JVI.01396.
    >> Share

  260. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    >> Share

  261. TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
    Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
    >> Share

  262. NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
    The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
    J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
    >> Share

  263. CHEN HY, Huang C, Tian L, Huang X, et al
    Cytoplasmic tail truncation of SARS-CoV-2 Spike protein enhances titer of pseudotyped vectors but masks the effect of the D614G mutation.
    J Virol. 2021 Sep 8:JVI0096621. doi: 10.1128/JVI.00966.
    >> Share

  264. CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
    A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
    J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
    >> Share

  265. ANDRADE ACDSP, Gabriel Campolina-Silva H, Queiroz-Junior CM, de Oliveira LC, et al
    A biosafety level-2 mouse model for studying betacoronavirus-induced acute lung damage and systemic manifestations.
    J Virol. 2021 Sep 8:JVI0127621. doi: 10.1128/JVI.01276.
    >> Share

    August 2021
  266. LI X, Wang L, Liu P, Li H, et al
    A novel potentially recombinant rodent coronavirus with a polybasic cleavage site in the spike protein.
    J Virol. 2021 Aug 25:JVI0117321. doi: 10.1128/JVI.01173.
    >> Share

  267. SHILIAEV N, Lukash T, Palchevska O, Crossman DK, et al
    Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.
    J Virol. 2021 Aug 18:JVI0135721. doi: 10.1128/JVI.01357.
    >> Share

  268. YANG YL, Liu J, Wang TY, Chen M, et al
    Aminopeptidase N is an entry co-factor triggering porcine deltacoronavirus entry via an endocytotic pathway.
    J Virol. 2021 Aug 18:JVI0094421. doi: 10.1128/JVI.00944.
    >> Share

  269. WANG G, Hu G, Liang R, Shi J, et al
    Establishment of Full-length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.
    J Virol. 2021 Aug 18:JVI0074521. doi: 10.1128/JVI.00745.
    >> Share

  270. KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
    Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
    J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
    >> Share

  271. LU M, Zhang Y, Dravid P, Li A, et al
    A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
    J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
    >> Share

    July 2021
  272. CANTWELL AM, Singh H, Platt M, Yu Y, et al
    Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.
    J Virol. 2021 Jul 28:JVI0101021. doi: 10.1128/JVI.01010.
    >> Share

  273. LI Z, Gao F, Lan Y, Guan J, et al
    Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
    J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
    >> Share

  274. WANG H, Kong N, Jiao Y, Dong S, et al
    EGR1 suppresses porcine epidemic diarrhea virus replication by regulating IRAV to degrade viral nucleocapsid protein.
    J Virol. 2021 Jul 21:JVI0064521. doi: 10.1128/JVI.00645.
    >> Share

  275. FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
    J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
    >> Share

  276. CHEN DY, Khan N, Close BJ, Goel RK, et al
    SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
    J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
    >> Share

  277. XU J, Mao J, Han X, Shi F, et al
    Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.
    J Virol. 2021 Jul 7:JVI0085321. doi: 10.1128/JVI.00853.
    >> Share

    June 2021
  278. NGUYEN HT, Falzarano D, Gerdts V, Liu Q, et al
    Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.
    J Virol. 2021 Jun 30:JVI0068721. doi: 10.1128/JVI.00687.
    >> Share

  279. SUN G, Sui Y, Zhou Y, Ya J, et al
    Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
    J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
    >> Share

  280. MEYER K, Patra T, Vijayamahantesh, Ray R, et al
    SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesionin endothelial cells.
    J Virol. 2021 Jun 23:JVI0079421. doi: 10.1128/JVI.00794.
    >> Share

  281. SILVAS JA, Morales Vasquez D, Park JG, Chiem K, et al
    Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice.
    J Virol. 2021 Jun 16:JVI0040221. doi: 10.1128/JVI.00402.
    >> Share

  282. LI A, Zhao K, Zhang B, Hua R, et al
    SARS-CoV-2 NSP12 protein is not an IFN-beta antagonist.
    J Virol. 2021 Jun 16:JVI0074721. doi: 10.1128/JVI.00747.
    >> Share

  283. KUMAR A, Ishida R, Strilets T, Cole J, et al
    SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    J Virol. 2021;95:e0026621.
    >> Share

  284. HAYASHI Y, Tsuchiya K, Yamamoto M, Nemoto-Sasaki Y, et al
    N-(4-Hydroxyphenyl) retinamide suppresses SARS-CoV-2 spike protein-mediated cell-cell fusion by a dihydroceramide Delta4-desaturase 1-independent mechanism.
    J Virol. 2021 Jun 9:JVI0080721. doi: 10.1128/JVI.00807.
    >> Share

  285. WANG X, Zhao Y, Yan F, Wang T, et al
    Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.
    J Virol. 2021 Jun 9:JVI0060021. doi: 10.1128/JVI.00600.
    >> Share

  286. QIN Y, Tu K, Teng Q, Feng D, et al
    Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine.
    J Virol. 2021 Jun 9:JVI0066721. doi: 10.1128/JVI.00667.
    >> Share

  287. OU J, Zhou Z, Dai R, Zhang J, et al
    V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
    J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
    >> Share

    May 2021
  288. SU M, Shi D, Xing X, Qi S, et al
    Coronavirus PEDV nucleocapsid protein interacts with p53 to induce cell cycle arrest in S-phase and promotes viral replication.
    J Virol. 2021 May 26:JVI0018721. doi: 10.1128/JVI.00187.
    >> Share

  289. LATOURRETTE K, Holste NM, Rodriguez-Pena R, Leme RA, et al
    Genome-wide variation in betacoronaviruses.
    J Virol. 2021 May 26:JVI0049621. doi: 10.1128/JVI.00496.
    >> Share

  290. DOSTALIK P, Krafcikova P, Silhan J, Kozic J, et al
    Structural analysis of the OC43 coronavirus 2'-O-RNA methyltransferase.
    J Virol. 2021 May 19. pii: JVI.00463-21. doi: 10.1128/JVI.00463.
    >> Share

  291. VOTH LS, O'Connor JJ, Kerr CM, Doerger E, et al
    Unique mutations in the MHV macrodomain differentially attenuate virus replication, indicating multiple roles for the macrodomain in coronavirus replication.
    J Virol. 2021 May 19. pii: JVI.00766-21. doi: 10.1128/JVI.00766.
    >> Share

  292. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
    J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
    >> Share

  293. CARNELL GW, Ciazynska KA, Wells DA, Xiong X, et al
    SARS-CoV-2 spike protein stabilized in the closed state induces potent neutralizing responses.
    J Virol. 2021 May 7. pii: JVI.00203-21. doi: 10.1128/JVI.00203.
    >> Share

  294. TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
    ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
    J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
    >> Share

  295. LULLA V, Wandel MP, Bandyra KJ, Ulferts R, et al
    Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome.
    J Virol. 2021 May 7. pii: JVI.00663-21. doi: 10.1128/JVI.00663.
    >> Share

  296. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    >> Share

    April 2021
  297. RESNICK SJ, Iketani S, Hong SJ, Zask A, et al
    Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity.
    J Virol. 2021 Apr 28. pii: JVI.02374-20. doi: 10.1128/JVI.02374.
    >> Share

  298. ALFI O, Yakirevitch A, Wald O, Wandel O, et al
    Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract.
    J Virol. 2021 Apr 23. pii: JVI.00130-21. doi: 10.1128/JVI.00130.
    >> Share

  299. VIDAL SJ, Collier AY, Yu J, McMahan K, et al
    Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
    J Virol. 2021 Apr 23. pii: JVI.00404-21. doi: 10.1128/JVI.00404.
    >> Share

  300. VERMA D, Mel Church T, Swaminathan S
    Epstein-Barr virus lytic replication induces ACE2 expression and enhances SARS CoV-2 pseudotyped virus entry in epithelial cells.
    J Virol. 2021 Apr 14. pii: JVI.00192-21. doi: 10.1128/JVI.00192.
    >> Share

  301. PATEL DR, Field CJ, Septer KM, Sim DG, et al
    Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
    J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
    >> Share

    March 2021
  302. LIU W, Reyes HM, Yang JF, Li Y, et al
    Activation of STING signaling pathway effectively blocks human coronavirus infection.
    J Virol. 2021 Mar 31. pii: JVI.00490-21. doi: 10.1128/JVI.00490.
    >> Share

  303. TOMITA Y, Matsuyama S, Fukuhara H, Maenaka K, et al
    The physiological TMPRSS2 inhibitor HAI-2 alleviates SARS-CoV-2 infection.
    J Virol. 2021 Mar 31. pii: JVI.00434-21. doi: 10.1128/JVI.00434.
    >> Share

  304. MORA-DIAZ JC, Pineyro PE, Rauh R, Nelson W, et al
    Porcine hemagglutinating encephalomyelitis virus infection in vivo and ex vivo.
    J Virol. 2021 Mar 24. pii: JVI.02335-20. doi: 10.1128/JVI.02335.
    >> Share

  305. YU J, Li Z, He X, Gebre MS, et al
    Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.
    J Virol. 2021 Mar 16. pii: JVI.00044-21. doi: 10.1128/JVI.00044.
    >> Share

  306. CHENG J, Zhao Y, Hu Y, Zhao J, et al
    The furin-S2' site in avian coronavirus plays a key role in central nervous system damage progression.
    J Virol. 2021 Mar 16. pii: JVI.02447-20. doi: 10.1128/JVI.02447.
    >> Share

  307. MA J, Su D, Sun Y, Huang X, et al
    Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19.
    J Virol. 2021 Mar 10. pii: JVI.00194-21. doi: 10.1128/JVI.00194.
    >> Share

  308. ZHANG Y, Huang K, Wang T, Deng F, et al
    SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia.
    J Virol. 2021 Mar 10. pii: JVI.02477-20. doi: 10.1128/JVI.02477.
    >> Share

  309. PALMER MV, Martins M, Falkenberg S, Buckley A, et al
    Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2.
    J Virol. 2021 Mar 10. pii: JVI.00083-21. doi: 10.1128/JVI.00083.
    >> Share

  310. JACOB-DOLAN C, Feldman J, McMahan K, Yu J, et al
    Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
    J Virol. 2021 Mar 10. pii: JVI.00117-21. doi: 10.1128/JVI.00117.
    >> Share

  311. LIU S, Selvaraj P, Lien CZ, Nunez IA, et al
    The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.
    J Virol. 2021 Mar 8. pii: JVI.01751-20. doi: 10.1128/JVI.01751.
    >> Share

  312. MA H, Zeng W, Meng X, Huang X, et al
    Potent Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain.
    J Virol. 2021 Mar 3. pii: JVI.02438-20. doi: 10.1128/JVI.02438.
    >> Share

  313. VOLOCH CM, da Silva Francisco R Jr, de Almeida LGP, Cardoso CC, et al
    Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.
    J Virol. 2021 Mar 1. pii: JVI.00119-21. doi: 10.1128/JVI.00119.
    >> Share

    February 2021
  314. DEINHARDT-EMMER S, Bottcher S, Haring C, Giebeler L, et al
    SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.
    J Virol. 2021 Feb 26. pii: JVI.00110-21. doi: 10.1128/JVI.00110.
    >> Share

  315. LE COUPANEC A, Desforges M, Kaufer B, Dubeau P, et al
    Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system.
    J Virol. 2021 Feb 24. pii: JVI.00140-21. doi: 10.1128/JVI.00140.
    >> Share

  316. DHAKAL S, Loube J, Misplon JA, Lo CY, et al
    Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
    J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
    >> Share

  317. DE VRIES M, Mohamed AS, Prescott RA, Valero-Jimenez AM, et al
    A comparative analysis of SARS-CoV-2 antivirals characterizes 3CL(pro) inhibitor PF-00835231 as a potential new treatment for COVID-19.
    J Virol. 2021 Feb 23. pii: JVI.01819-20. doi: 10.1128/JVI.01819.
    >> Share

  318. HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
    SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
    J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
    >> Share

  319. SUN L, Chen H, Ming X, Bo Z, et al
    Porcine Epidemic Diarrhea Virus Infection Induces Caspase-8 mediated G3BP1 Cleavage and Subverts Stress Granules to Promote Viral Replication.
    J Virol. 2021 Feb 10. pii: JVI.02344-20. doi: 10.1128/JVI.02344.
    >> Share

  320. WINSTONE H, Lista MJ, Reid AC, Bouton C, et al
    The polybasic cleavage site in the SARS-CoV-2 spike modulates viral sensitivity to Type I interferon and IFITM2.
    J Virol. 2021 Feb 9. pii: JVI.02422-20. doi: 10.1128/JVI.02422.
    >> Share

    January 2021
  321. REBENDENNE A, Valadao ALC, Tauziet M, Maarifi G, et al
    SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.
    J Virol. 2021 Jan 29. pii: JVI.02415-20. doi: 10.1128/JVI.02415.
    >> Share

  322. DAGOTTO G, Mercado NB, Martinez DR, Hou YJ, et al
    Comparison of Subgenomic and Total RNA in SARS-CoV-2 Challenged Rhesus Macaques.
    J Virol. 2021 Jan 20. pii: JVI.02370-20. doi: 10.1128/JVI.02370.
    >> Share

  323. DOMINGO E, Perales C
    The time for COVID-19 vaccination.
    J Virol. 2021 Jan 19. pii: JVI.02437-20. doi: 10.1128/JVI.02437.
    >> Share

  324. CHEN JS, Alfajaro MM, Chow RD, Wei J, et al
    Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection.
    J Virol. 2021 Jan 13. pii: JVI.00014-21. doi: 10.1128/JVI.00014.
    >> Share

  325. CHIEM K, Morales Vasquez D, Park JG, Platt RN, et al
    Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
    J Virol. 2021 Jan 11. pii: JVI.02209-20. doi: 10.1128/JVI.02209.
    >> Share

  326. SHI Y, Shi J, Sun L, Tan Y, et al
    Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    J Virol. 2021 Jan 7. pii: JVI.02284-20. doi: 10.1128/JVI.02284.
    >> Share

  327. GARCIA-ARRIAZA J, Garaigorta U, Perez P, Lazaro-Frias A, et al
    COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.
    J Virol. 2021 Jan 7. pii: JVI.02260-20. doi: 10.1128/JVI.02260.
    >> Share

    December 2020
  328. ZHAO J, Sun L, Zhao Y, Feng D, et al
    Coronavirus Endoribonuclease Ensures Efficient Viral Replication and Prevents Protein Kinase R Activation.
    J Virol. 2020 Dec 23. pii: JVI.02103-20. doi: 10.1128/JVI.02103.
    >> Share

  329. LEE E, Sandgren K, Duette G, Stylianou VV, et al
    Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
    J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
    >> Share

  330. NGUYEN HT, Zhang S, Wang Q, Anang S, et al
    Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
    J Virol. 2020 Dec 11. pii: JVI.02304-20. doi: 10.1128/JVI.02304.
    >> Share

  331. TAKAGI A, Matsui M
    Identification of HLA-A*02:01-restricted candidate epitopes derived from the non-structural polyprotein 1a of SARS-CoV-2 that may be natural targets of CD8(+) T cell recognition in vivo.
    J Virol. 2020 Dec 2. pii: JVI.01837-20. doi: 10.1128/JVI.01837.
    >> Share

  332. TAVARES RCA, Mahadeshwar G, Wan H, Huston NC, et al
    The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.
    J Virol. 2020 Dec 2. pii: JVI.02190-20. doi: 10.1128/JVI.02190.
    >> Share

    November 2020
  333. PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
    A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
    J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
    >> Share

  334. YUAN LX, Liang JQ, Zhu QC, Dai G, et al
    Gammacoronavirus Avian Infectious Bronchitis Virus and Alphacoronavirus Porcine Epidemic Diarrhea Virus Exploit a Cell-Survival Strategy via Upregulation of cFOS to Promote Viral Replication.
    J Virol. 2020 Nov 25. pii: JVI.02107-20. doi: 10.1128/JVI.02107.
    >> Share

  335. WESTERGREN JAKOBSSON A, Segerman B, Wallerman O, Lind SB, et al
    The Human Adenovirus Type 2 Transcriptome: An Amazing Complexity of Alternatively Spliced mRNAs.
    J Virol. 2020 Nov 25. pii: JVI.01869-20. doi: 10.1128/JVI.01869.
    >> Share

  336. CLARK LK, Green TJ, Petit CM
    Structure of nonstructural protein 1 from SARS-CoV-2.
    J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
    >> Share

  337. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    >> Share

  338. UJIKE M, Kawachi Y, Matsunaga Y, Etho Y, et al
    Characterization of localization and export signals of bovine torovirus nucleocapsid protein responsible for extensive nuclear and nucleolar accumulation and their importance for virus growth.
    J Virol. 2020 Nov 11. pii: JVI.02111-20. doi: 10.1128/JVI.02111.
    >> Share

  339. TANDON R, Sharp JS, Zhang F, Pomin VH, et al
    Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    J Virol. 2020 Nov 10. pii: JVI.01987-20. doi: 10.1128/JVI.01987.
    >> Share

  340. ALHAMMAD YMO, Kashipathy MM, Roy A, Gagne JP, et al
    The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
    J Virol. 2020 Nov 6. pii: JVI.01969-20. doi: 10.1128/JVI.01969.
    >> Share

  341. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    >> Share

  342. HEISE M, Dermody TS, Casadevall A, Sandri-Goldin RM, et al
    The Decision to Publish Gutierrez-Alvarez et al., "Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice".
    J Virol. 2020 Nov 3. pii: JVI.02118-20. doi: 10.1128/JVI.02118.
    >> Share

  343. GUTIERREZ-ALVAREZ J, Wang L, Fernandez-Delgado R, Li K, et al
    Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice.
    J Virol. 2020 Nov 3. pii: JVI.01172-20. doi: 10.1128/JVI.01172.
    >> Share

    October 2020
  344. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    >> Share

  345. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    >> Share

  346. LI Y, Yang N, Chen J, Huang X, et al
    Next-Generation Porcine Intestinal Organoids: an Apical-Out Organoid Model for Swine Enteric Virus Infection and Immune Response Investigations.
    J Virol. 2020;94.
    >> Share

    September 2020
  347. SYAGE AR, Ekiz HA, Skinner DD, Stone C, et al
    Single-cell RNA sequencing reveals the diversity of the immunological landscape following CNS infection by a murine coronavirus.
    J Virol. 2020 Sep 30. pii: JVI.01295-20. doi: 10.1128/JVI.01295.
    >> Share

  348. HU Y, Li W, Gao T, Cui Y, et al
    Correction for Hu et al., "The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination".
    J Virol. 2020;94.
    >> Share

  349. XU S, Zhou J, Chen Y, Tong X, et al
    Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease.
    J Virol. 2020;94.
    >> Share

  350. CHOI JA, Goo J, Yang E, Jung DI, et al
    Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    J Virol. 2020 Sep 23. pii: JVI.01176-20. doi: 10.1128/JVI.01176.
    >> Share

  351. OGANDO NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, et al
    The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2.
    J Virol. 2020 Sep 16. pii: JVI.01246-20. doi: 10.1128/JVI.01246.
    >> Share

  352. LOKUGAMAGE KG, Hage A, de Vries M, Valero-Jimenez AM, et al
    Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
    J Virol. 2020 Sep 16. pii: JVI.01410-20. doi: 10.1128/JVI.01410.
    >> Share

  353. CHANDRASEKAR SS, Kingstad-Bakke B, Wu CW, Suresh M, et al
    A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
    J Virol. 2020;94.
    >> Share

  354. BROCATO RL, Principe LM, Kim RK, Zeng X, et al
    Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
    J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
    >> Share

    August 2020
  355. LI Y, Wang H, Tang X, Fang S, et al
    SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig.
    J Virol. 2020 Aug 26. pii: JVI.01283-20. doi: 10.1128/JVI.01283.
    >> Share

  356. FROGGATT HM, Heaton BE, Heaton NS
    Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
    J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
    >> Share

  357. GUAN H, Wang Y, Perculija V, Saeed AFUH, et al
    Cryo-electron microscopy structure of the SADS-CoV spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins.
    J Virol. 2020 Aug 19. pii: JVI.01301-20. doi: 10.1128/JVI.01301.
    >> Share

  358. WESTON S, Coleman CM, Haupt R, Logue J, et al
    Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
    J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
    >> Share

  359. SI F, Chen B, Hu X, Yu R, et al
    Porcine Epidemic Diarrhea Virus ORF3 Protein Is Transported through the Exocytic Pathway.
    J Virol. 2020;94.
    >> Share

  360. HWANG M, Bergmann CC
    Neuronal ablation of IFNalpha/beta signaling exacerbates CNS viral dissemination and impairs IFNgamma responsiveness in microglia/macrophages.
    J Virol. 2020 Aug 12. pii: JVI.00422-20. doi: 10.1128/JVI.00422.
    >> Share

  361. JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
    Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
    J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
    >> Share

    July 2020
  362. GUO H, Hu BJ, Yang XL, Zeng LP, et al
    Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.
    J Virol. 2020 Jul 22. pii: JVI.00902-20. doi: 10.1128/JVI.00902.
    >> Share

  363. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    >> Share

  364. WANG Y, Sun J, Li X, Zhu A, et al
    Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo.
    J Virol. 2020;94.
    >> Share

  365. AHLEN G, Frelin L, Nekoyan N, Weber F, et al
    The SARS-CoV-2 N protein is a good component in a vaccine.
    J Virol. 2020 Jul 13. pii: JVI.01279-20. doi: 10.1128/JVI.01279.
    >> Share

  366. ZHAO X, Chen D, Szabla R, Zheng M, et al
    Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
    J Virol. 2020 Jul 13. pii: JVI.00940-20. doi: 10.1128/JVI.00940.
    >> Share

  367. SMITH M, Honce R, Schultz-Cherry S
    Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses.
    J Virol. 2020 Jul 13. pii: JVI.00665-20. doi: 10.1128/JVI.00665.
    >> Share

  368. TABOADA B, Vazquez-Perez JA, Munoz Medina JE, Ramos Cervantes P, et al
    Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
    J Virol. 2020 Jul 8. pii: JVI.01056-20. doi: 10.1128/JVI.01056.
    >> Share

  369. ZHAO X, Zheng S, Chen D, Zheng M, et al
    LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
    J Virol. 2020 Jul 8. pii: JVI.00562-20. doi: 10.1128/JVI.00562.
    >> Share

  370. DERVAS E, Hepojoki J, Smura T, Prahauser B, et al
    Serpentoviruses, more than respiratory pathogens.
    J Virol. 2020 Jul 8. pii: JVI.00649-20. doi: 10.1128/JVI.00649.
    >> Share

  371. CHAKRAVARTY D, Saadi F, Kundu S, Bose A, et al
    CD4 Deficiency Causes Poliomyelitis and Axonal Blebbing in Murine Coronavirus-Induced Neuroinflammation.
    J Virol. 2020;94.
    >> Share

  372. DALMANN A, Reimann I, Wernike K, Beer M, et al
    Autonomously Replicating RNAs of Bungowannah Pestivirus: E(RNS) Is Not Essential for the Generation of Infectious Particles.
    J Virol. 2020;94.
    >> Share

  373. YIN L, Chen J, Li L, Guo S, et al
    Aminopeptidase N Expression, Not Interferon Responses, Determines the Intestinal Segmental Tropism of Porcine Deltacoronavirus.
    J Virol. 2020;94.
    >> Share

    June 2020
  374. MOORE JP, Klasse PJ
    SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
    J Virol. 2020 Jun 26. pii: JVI.01083-20. doi: 10.1128/JVI.01083.
    >> Share

  375. LIU Z, Zheng H, Lin H, Li M, et al
    Identification of common deletions in the spike protein of SARS-CoV-2.
    J Virol. 2020 Jun 22. pii: JVI.00790-20. doi: 10.1128/JVI.00790.
    >> Share

  376. DENG X, Buckley AC, Pillatzki A, Lager KM, et al
    Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    J Virol. 2020 Jun 17. pii: JVI.00565-20. doi: 10.1128/JVI.00565.
    >> Share

  377. DUTTA NK, Mazumdar K, Gordy JT
    The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    J Virol. 2020;94.
    >> Share

  378. STRAUS MR, Tang T, Lai AL, Flegel A, et al
    Ca(2+) Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity.
    J Virol. 2020;94.
    >> Share

  379. CHANG CY, Liu HM, Chang MF, Chang SC, et al
    Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    J Virol. 2020;94.
    >> Share

    May 2020
  380. LU Y, Cai H, Lu M, Ma Y, et al
    Porcine epidemic diarrhea virus deficient in RNA cap guanine-N-7 methylation is attenuated and induces higher type I and III interferon responses.
    J Virol. 2020 May 27. pii: JVI.00447-20. doi: 10.1128/JVI.00447.
    >> Share

  381. ZHU X, Chen J, Tian L, Zhou Y, et al
    Porcine Deltacoronavirus nsp5 Cleaves DCP1A to Decrease Its Antiviral Ability.
    J Virol. 2020 May 27. pii: JVI.02162-19. doi: 10.1128/JVI.02162.
    >> Share

  382. MILEWSKA A, Kula-Pacurar A, Wadas J, Suder A, et al
    Replication of SARS-CoV-2 in human respiratory epithelium.
    J Virol. 2020 May 20. pii: JVI.00957-20. doi: 10.1128/JVI.00957.
    >> Share

  383. VOLK A, Hackbart M, Deng X, Cruz-Pulido Y, et al
    Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.
    J Virol. 2020;94.
    >> Share

  384. DENG X, Chen Y, Mielech AM, Hackbart M, et al
    Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.
    J Virol. 2020;94.
    >> Share

  385. ZHAI X, Sun J, Yan Z, Zhang J, et al
    Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.
    J Virol. 2020 May 13. pii: JVI.00831-20. doi: 10.1128/JVI.00831.
    >> Share

  386. ZHU Y, Yu D, Yan H, Chong H, et al
    Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.
    J Virol. 2020 May 6. pii: JVI.00635-20. doi: 10.1128/JVI.00635.
    >> Share

  387. HOLLAND LA, Kaelin EA, Maqsood R, Estifanos B, et al
    An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020).
    J Virol. 2020 May 1. pii: JVI.00711-20. doi: 10.1128/JVI.00711.
    >> Share

    April 2020
  388. NGUYEN A, David JK, Maden SK, Wood MA, et al
    Human leukocyte antigen susceptibility map for SARS-CoV-2.
    J Virol. 2020 Apr 17. pii: JVI.00510-20. doi: 10.1128/JVI.00510.
    >> Share

  389. WANG M, Li M, Ren R, Li L, et al
    International expansion of a novel SARS-CoV-2 mutant.
    J Virol. 2020 Apr 8. pii: JVI.00567-20. doi: 10.1128/JVI.00567.
    >> Share

  390. LICASTRO D, Rajasekharan S, Dal Monego S, Segat L, et al
    Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy.
    J Virol. 2020 Apr 1. pii: JVI.00543-20. doi: 10.1128/JVI.00543.
    >> Share

  391. CAGLIANI R, Forni D, Clerici M, Sironi M, et al
    Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2.
    J Virol. 2020 Apr 1. pii: JVI.00411-20. doi: 10.1128/JVI.00411.
    >> Share

    January 2020
  392. WAN Y, Shang J, Graham R, Baric RS, et al
    Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.
    J Virol. 2020 Jan 29. pii: JVI.00127-20. doi: 10.1128/JVI.00127.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016